Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Age: Adult |
Dose: Concentrate – 5 lit. Frequency: per dialysis Note: or as required |
| Clinical Information | Administration Information |
|---|---|
|
Indication: Metabolic Acidosis Age: Neonates and children less than 2 years |
Dose: Intravenous – 1 mmol/kg |
|
Indication: Metabolic Acidosis Age: Children greater than 2 years |
Dose: Intravenous – 1 mmol/kg |
| Drug Name | Risk Factors |
|---|---|
|
Amphetamines, Ephedrine, Pseudoephedrine, Flecainide, Quinidine, Quinine
|
Increases toxicity
|
|
Lithium, Chlorpropamide, Salicylates
|
Decreases effects due to increased clearance
|
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.